Back to companies

Beijing SL Pharmaceutical Co Ltd: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Beijing SL Pharmaceutical Co Ltd (SL Pharma) is a biopharmaceutical company that develops and markets gene engineering drugs. The company carries out research, development, production and management of genetic engineering and biochemical drugs. It provides active pharmaceutical ingredients including filgrastim, L-asparaginase, PEG L-asparaginase, rh bFGF, rh interleukin-11, rh somatotropin, gemcitabine, tropisetrion, adefovir, temozolomide, lenalidomide, dasatinib, imatinib, enoxaparin, and others. SL Pharma's products are available in the field of oncology, organ transplantation, wound management, cardiovascular, and others. Its oncology products include filgrastim, paclitaxel, asparaginase, peg-asparaginase, granisetron hydrochloride, tropisetron hydrochloride, arsenic trioxide, temozolomide and others. The company is also developing DT-110, an orally active tripeptide to lower blood glucose, lower blood pressure. It markets products throughout the network of distributors located across China. SL Pharma is headquartered in Beijing, China

Headquarters China

Address No. 69 Fushi Road, Haidian District, Beijing, 100143


Telephone 86 10 88627635

No of Employees 761

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 002038 (SHE)

Revenue (2021) $188.3M -45.2% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -25.1% (2021 vs 2020)

Market Cap* $1.5B

Net Profit Margin (2020) XXX 36.7% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

50+

Marketed Drugs

Understand Beijing SL Pharmaceutical Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

40+

Clinical Trials

Determine Beijing SL Pharmaceutical Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

8

Pipeline Drugs

Identify which of Beijing SL Pharmaceutical Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Beijing SL Pharmaceutical Co Ltd’s relevant decision makers and contact details.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Active Pharmaceutical Ingredients:
Filgrastim
L-Asparaginase
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More
Image for loader

Competitor Comparison

Key Parameters Beijing SL Pharmaceutical Co Ltd CSPC Pharmaceutical Group Ltd Cachet Pharmaceutical Co Ltd Walvax Biotechnology Co Ltd Hainan Haiyao Co Ltd
Headquarters China China China China China
City Beijing Shijiazhuang Beijing Kunming Haikou
State/Province Beijing Hebei Beijing Yunnan Hainan
No. of Employees 761 24,746 3,149 1,866 2,589
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Xu Mingbo General Manager; Chairman Executive Board 2006 58
Liang Shujie Director; President Executive Board 2009 56
Li Yajun Chief Financial Officer; Deputy General Manager Senior Management 2021 45
Wang Wenxin Director Non Executive Board 2013 56
Qian Lingjia Director Non Executive Board 2021 67
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer